121 related articles for article (PubMed ID: 7980522)
1. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin.
Sires UI; Murphy G; Baragi VM; Fliszar CJ; Welgus HG; Senior RM
Biochem Biophys Res Commun; 1994 Oct; 204(2):613-20. PubMed ID: 7980522
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin.
Zhang Z; Winyard PG; Chidwick K; Murphy G; Wardell M; Carrell RW; Blake DR
Biochim Biophys Acta; 1994 Mar; 1199(2):224-8. PubMed ID: 8123672
[TBL] [Abstract][Full Text] [Related]
3. Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.
Vissers MC; George PM; Bathurst IC; Brennan SO; Winterbourn CC
J Clin Invest; 1988 Aug; 82(2):706-11. PubMed ID: 2841359
[TBL] [Abstract][Full Text] [Related]
4. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
Welch AR; Holman CM; Huber M; Brenner MC; Browner MF; Van Wart HE
Biochemistry; 1996 Aug; 35(31):10103-9. PubMed ID: 8756473
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin.
Winyard PG; Zhang Z; Chidwick K; Blake DR; Carrell RW; Murphy G
FEBS Lett; 1991 Feb; 279(1):91-4. PubMed ID: 1995350
[TBL] [Abstract][Full Text] [Related]
6. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites.
Sires UI; Griffin GL; Broekelmann TJ; Mecham RP; Murphy G; Chung AE; Welgus HG; Senior RM
J Biol Chem; 1993 Jan; 268(3):2069-74. PubMed ID: 8380588
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
Kress LF
J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin).
Mast AE; Enghild JJ; Nagase H; Suzuki K; Pizzo SV; Salvesen G
J Biol Chem; 1991 Aug; 266(24):15810-6. PubMed ID: 1651920
[TBL] [Abstract][Full Text] [Related]
9. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
[TBL] [Abstract][Full Text] [Related]
10. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Pei D; Majmudar G; Weiss SJ
J Biol Chem; 1994 Oct; 269(41):25849-55. PubMed ID: 7523394
[TBL] [Abstract][Full Text] [Related]
11. Matrilysin expression in human prostate carcinoma.
Knox JD; Wolf C; McDaniel K; Clark V; Loriot M; Bowden GT; Nagle RB
Mol Carcinog; 1996 Jan; 15(1):57-63. PubMed ID: 8561867
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
Baragi VM; Fliszar CJ; Conroy MC; Ye QZ; Shipley JM; Welgus HG
J Biol Chem; 1994 Apr; 269(17):12692-7. PubMed ID: 8175679
[TBL] [Abstract][Full Text] [Related]
14. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
15. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Uría JA; López-Otín C
Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
[TBL] [Abstract][Full Text] [Related]
16. Metal and pH dependence of heptapeptide catalysis by human matrilysin.
Cha J; Pedersen MV; Auld DS
Biochemistry; 1996 Dec; 35(49):15831-8. PubMed ID: 8961947
[TBL] [Abstract][Full Text] [Related]
17. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
Anthony DC; Ferguson B; Matyzak MK; Miller KM; Esiri MM; Perry VH
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):406-15. PubMed ID: 9364466
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of beta 4 integrin by matrilysin.
von Bredow DC; Nagle RB; Bowden GT; Cress AE
Exp Cell Res; 1997 Oct; 236(1):341-5. PubMed ID: 9344615
[TBL] [Abstract][Full Text] [Related]
19. Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones?
Chen B; Wen Y; Yu X; Polan ML
Am J Obstet Gynecol; 2005 May; 192(5):1605-13. PubMed ID: 15902165
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases.
Desrochers PE; Mookhtiar K; Van Wart HE; Hasty KA; Weiss SJ
J Biol Chem; 1992 Mar; 267(7):5005-12. PubMed ID: 1311327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
